stoxline Quote Chart Rank Option Currency Glossary
  
ViewRay, Inc. (VRAY)
0.025  -0.017 (-39.9%)    07-25 16:00
Open: 0.0397
High: 0.0397
Volume: 96,174,239
  
Pre. Close: 0.0416
Low: 0.025
Market Cap: 5(M)
Technical analysis
2023-10-20 4:27:13 PM
Short term     
Mid term     
Targets 6-month :  0.01 1-year :  0.02
Resists First :  0.01 Second :  0.01
Pivot price 0.01
Supports First :  0 Second :  0
MAs MA(5) :  0 MA(20) :  0.01
MA(100) :  0.31 MA(250) :  2.5
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  25.1 D(3) :  22.7
RSI RSI(14): 26.8
52-week High :  4.96 Low :  0
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VRAY ] has closed above bottom band by 23.0%. Bollinger Bands are 97.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 35 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.01 - 0.01 0.01 - 0.01
Low: 0.01 - 0.01 0.01 - 0.01
Close: 0.01 - 0.01 0.01 - 0.01
Company Description

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Headline News

Tue, 25 Jul 2023
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.08% By Investing.com - Investing.com

Fri, 21 Jul 2023
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading ... - PR Newswire

Thu, 20 Jul 2023
ViewRay files for bankruptcy, eyes sale of MRI radiotherapy tech - Fierce Biotech

Mon, 17 Jul 2023
ViewRay® Files Voluntary Chapter 11 Petitions - PR Newswire

Mon, 17 Jul 2023
Why Is ViewRay (VRAY) Stock Down 69% Today? - InvestorPlace

Fri, 07 Jul 2023
ViewRay: Near-Term Bankruptcy Filing Might Be In The Cards - Sell (NASDAQ:VRAY) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0.05
Sales Per Share 0.57
EBITDA (p.s.) -0.57
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0.01
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android